Therapeutic effects of breviscapine in cardiovascular diseases: A review

Frontiers in Pharmacology

Volumn 8, Issue MAY, 2017, Pages

  Gao, Jialiang ^a   Chen, Guang ^a,b   He, Haoqiang ^a,b   Liu, Chao ^a,b   Xiong, Xingjiang ^a   Li, Jun ^a   Wang, Jie ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Breviscapine; Chinese medicine; Ethnopharmacology; Herbal active compounds; Herbal medicine

Indexed keywords

BREVISCAPINE;

ADVERSE OUTCOME; ANTIARRHYTHMIC ACTIVITY; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR DISEASE; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CHEMICAL COMPOSITION; CHEST TIGHTNESS; CLINICAL STUDY; COR PULMONALE; DIZZINESS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; ERECTILE DYSFUNCTION; GASTROINTESTINAL DISEASE; HEADACHE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART PALPITATION; HEART PROTECTION; HOT FLUSH; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; NONHUMAN; PRURITUS; RASH; REPERFUSION INJURY; REVIEW; VASCULAR ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE CELL; VASODILATATION; VERTIGO; VIRUS MYOCARDITIS;

EID: 85019547984     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00289     Document Type: Review

References (105)

1. Bo, L. I., Zhao, G. A., Yin, G. T., Sun, H. Y., Gao-Ling, G. U., and Yang, X. L. (2011). Effect of breviscapine tablets on ventricular arrhythmias in hypertrophic myocardium of rabbit heart. J. Xinxiang Med. Coll. 2, 154-156
2. Bolotina, V. M., Najibi, S., Palacino, J. J., Pagano, P. J., and Cohen, R. A. (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368, 850-853. doi: 10.1038/368850a0
3. Cao, R. B., Li-Hua, H. E., and Xiu-Zhen, H. E. (2006). Curative effects of eriseron breviscapus injection upon acutely aggravating stage of cor pulmonale. China J. Mod. Med. 16, 1560-1563
4. Cao, W., Liu, W., Wu, T., Zhong, D., and Liu, G. (2008). Dengzhanhua preparations for acute cerebral infarction. Cochrane Database Syst. Rev. 63:CD005568. doi: 10.1002/14651858.CD005568.pub2
5. Chen, J. P., Ren, X. S., Sun, Z. H., and Guo, Z. Y. (2015). Protective effects and mechanisms of breviscapine on endothelial cells. J. Chin. Pharm. Univ. 5, 610-616
6. Deng, C. Y., Tang, C. J., Kuang, S. J., Qian, W. M., Zi-Cheng, L. I., Wu, S. L., et al. (2008). Effect of breviscapin on I_(to) and I_(k1) channel current in isolated ventricular myocytes of rats. Chin. J. Pathophysiol. 24, 84-88
7. Duan, W. H., Lu, F., Li, L. Z., Wang, C. L., Liu, J. G., and Yang, W. H. (2012). Clinical efficacy of traditional chinese medicine on acute myocardial infarction: a prospective cohort study. Chin. J. Integr. Med. 18, 807-812. doi: 10.1007/s11655-012-1116-9
8. Ernst, E. (2005). Complementary/alternative medicine for hypertension: a mini-review. Wien. Med. Wochenschr. 155, 386-391. doi: 10.1007/s10354-005-0205-1
9. ESH/ESC Task Force for the Management of Arterial Hypertension (2013). 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J. Hypertens. 31, 1925-1938. doi: 10.1097/HJH.0b013e328364ca4c
10. Feng, Y., Chen, H. Y., Yao, G. T., and Jin, N. M. (2016). Meta-analysis of clinical adverse reactions induced by breviscapine injection. J. Shanghai Univ. Tradit. Chin. Med. 4, 85-91
11. Fintel, D. J. (2012). Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options. Vasc. Health Risk Manag. 8, 77-89. doi: 10.2147/VHRM.S26030
12. Furchgott, R. F. (1983). Role of endothelium in responses of vascular smooth muscle. Circ. Res. 53:557. doi: 10.1161/01.RES.53.5.557
13. Gao, X., and Liang, Q. (2009). Observe the curative effect of breviscapine in the treatment of chronic pulmonary heart disease. Inf. Tradit. Chin. Med. 26, 41-42
14. GBD 2013 Mortality and Causes of Death Collaborators (2015). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet 385, 117-171. doi: 10.1016/S0140-6736(14)61682-2
15. Gong, M. Y., Du, C., and Yuan, B. Y. (2013). The effect of breviscapine on myocardial ischemia reperfusion in rats serum TNF-and IL-6. Lishizhen Med. Mater. Med. Res. 24, 1615-1616
16. Gu, D., Huang, G., and He, J. (2002). Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population. Chin. J. Cardiol. 31, 3-6
17. Gu, J., Bao, Q., Zhang, S., and Lei, S. (2014). Effects of dengzhanhuasu injection on deceleration capacity of heart rate in children with viral myocarditis. J. Pediatr. Pharm. 3, 23-25
18. Gu, T. B., Shang, C. L., and Wang, W. X. (2002). Observation on acute myocardiac infarction treated by fleabane injection. J. Pract. Tradit. Chin. Med. 18, 8-9
19. Han, F. (1999). Clinical observation on the treatment of Erigeron breviscapus injection for 30 cases of persistent atrial fibrillation. Med. J. Chin. Peoples Health 4, 57-58
20. Hao, X., Cheng, G., Sun, J., Zou, M., Yu, J., Zang, S., et al. (2005). Validation of an hplc method for the determination of scutellarin in rat plasma and its pharmacokinetics. J. Pharm. Biomed. Anal. 38, 360-363. doi: 10.1016/j.jpba.2005.01.004
21. He, M., Xue, Z., Li, J., and Zhou, B. (2012). Breviscapine inhibits high glucose-induced proliferation and migration of cultured vascular smooth muscle cells of rats via suppressing the erk1/2 mapk signaling pathway. Acta Pharmacol. Sin. 33, 606-614. doi: 10.1038/aps.2012.6
22. Hou, S. S., Zhang, Q. H., and Zhang, Y. Q. (2009). The effect of breviscapine and thrombin receptor oligo-deoxy-nucleotides on thrombin induced proliferation of rat aortic smooth muscle cells. Tianjin Pharm. 19, 6-9
23. Jia, J. H., Chen, K. P., Chen, S. X., Liu, K. Z., Fan, T. L., and Chen, Y. C. (2008). Breviscapine, a traditional Chinese medicine, alleviates myocardial ischaemia reperfusion injury in diabetic rats. Acta Cardiol. 63, 757-762. doi: 10.2143/AC.63.6.2033394
24. Kong, Q., Dai, L., Wang, Y., Zhang, X., Li, C., Jiang, S., et al. (2016). Hspa12b attenuated acute myocardial ischemia/reperfusion injury via maintaining endothelial integrity in a pi3k/akt/mtor-dependent mechanism. Sci. Rep. 6:33636. doi: 10.1038/srep33636
25. Kong, Q. F., Wei-Guo, L. I., Liu, F., Shen, Y. M., and Feng-Lan, L. I. (2006). Effect of breviscapine injection on the erythrocyte deformability, leukocyte activation and adhesive molecule cd11b expression in patients with decompensable chronic cor pulmonale. Int. J. Tradit. Chin. Med. 28, 278-281
26. Lenzo, J. C., Fairweather, D. L., Shellam, G. R., and Lawson, C. M. (2001). Immunomodulation of murine cytomegalovirus-induced myocarditis in mice treated with lipopolysaccharide and tumor necrosis factor. Cell. Immunol. 213, 52-61. doi: 10.1006/cimm.2001.1859
27. Li, C. (2007). The effects of dengzhanhuasu injection on cardiac function and exercise capacity in patients with severe congestive heart failure. Chin. J. Mod. Drug Appl. 1, 4-6
28. Li, X. L., Li, Y. Q., Yan, W. M., Li, H. Y., Xu, H., Zheng, X. X., et al. (2004). A study of the cardioprotective effect of breviscapine during hypoxia of cardiomyocytes. Planta Med. 70, 1039-1044. doi: 10.1055/s-2004-832644
29. Li, Y., Jiang, J., He, Y., Jiang, R., Liu, J., Fan, Z., et al. (2014). Icariin combined with breviscapine improves the erectile function of spontaneously hypertensive rats. J. Sex. Med. 11, 2143-2152. doi: 10.1111/jsm.12614
30. Li, Z. Z. (2011). The effect of breviscapine on hemodynamics in CHF rats. Harbing Med. J. 31, 426-427
31. Lin, L., Hua, L., Cai, H. Y., and Yang, W. M. (2011). Effects of scutellarin on vascular endothelial growth factor and protein kinase cε expression in human umbilical vein endothelial cells after ischemia-reperfusion injury. J. Clin. Rehabil. Tissue Eng. Res. 20, 3723-3727
32. Lin, L., Liu, A. J., Yu, X., Qin, L., and Su, D. (2007). Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats. J. Cardiovasc. Pharmacol. 50, 327-332. doi: 10.1097/FJC.0b013e3180cbd0e7
33. Liu, X., Yao, L., Sun, D., Zhu, X., Liu, Q., Xu, T., et al. (2016). Effect of breviscapine injection on clinical parameters in diabetic nephropathy: a meta-analysis of randomized controlled trials. Exp. Ther. Med. 12, 1383-1397. doi: 10.3892/etm.2016.3483
34. Liu, Y., Li, X., Yang, C., Tai, S., Zhang, X., and Liu, G. (2013). Uplc-MS-MS method for simultaneous determination of caffeine, tolbutamide, metoprolol, and dapsone in rat plasma and its application to cytochrome p450 activity study in rats. J. Chromatogr. Sci. 51, 26-32. doi: 10.1093/chromsci/bms100
35. Liu, Y. P., and Bai, S. Q. (2012). Analysis of 12 cases of adverse reactions of breviscapine. Nei Mongol J. Tradit. Chin. Med. 31, 49-50
36. Liu, Z. L., Liu, Z. J., Liu, J. P., Yang, M., and Kwong, J. (2012). Herbal medicines for viral myocarditis. Cochrane Database Syst. Rev. 11:CD003711. doi: 10.1002/14651858.CD003711.pub5
37. Lou, L., and Liu, H. (2009). Study on the mechanism of breviscapine to renal hypertrophy in type 2 diabetic rats. Lishizhen Med. Mater. Med. Res. 20, 86-87
38. Lu, J., Cheng, C., Zhao, X., Liu, Q., Yang, P., Wang, Y., et al. (2010). PEG-scutellarin prodrugs: synthesis, water solubility and protective effect on cerebral ischemia/reperfusion injury. Eur. J. Med. Chem. 45, 1731-1738. doi: 10.1016/j.ejmech.2010.01.006
39. Ma, Y., Li, H., and Guan, S. (2015). Enhancement of the oral bioavailability of breviscapine by nanoemulsions drug delivery system. Drug Dev. Ind. Pharm. 41, 177-182. doi: 10.3109/03639045.2014.947510
40. Marx, J. L. (1982). Coagulation as a common thread in disease. Science 218, 145-146. doi: 10.1126/science.7123225
41. Mcmurray, J. J., and Pfeffer, M. A. (2005). Heart failure. Lancet 365, 1877-1889. doi: 10.1016/S0140-6736(05)66621-4
42. Mehra, R. (2007). Global public health problem of sudden cardiac death. J. Electrocardiol. 40, S118-S122. doi: 10.1016/j.jelectrocard.2007.06.023
43. Mendis, S., Puska, P., Norrving, B., Mendis, S., Puska, P., and Norrving, B. (2011). Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: World Health Organization
44. Ming, G., Yue, L., and Shi, D. (2016). Cardiovascular actions and therapeutic potential of tetramethylpyrazine (active component isolated from Rhizoma Chuanxiong): roles and mechanisms. Biomed. Res. Int. 2016:2430329. doi: 10.1155/2016/2430329
45. Munger, T. M., Wu, L. Q., and Shen, W. K. (2014). Atrial fibrillation. J. Biomed. Res. 28, 1-17
46. National Clinical Guideline Centre (2010). Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update. London: Royal College of Physicians
47. Nie, X. L., Shen, H., Xie, Y. M., Hu, J., Zhang, Y. L., and Li, Y. Y. (2012). Meta-analysis of dengzhanxixin injection treatment for unstable angina pectoris. China J. Chin. Mater.Med. 37, 2768-2773
48. Pakala, R., Liang, C. T., and Benedict, C. R. (2001). A peptide analogue of thrombin receptor-activating peptide inhibits thrombin and thrombin-receptor-activating peptide-induced vascular smooth muscle cell proliferation. J. Cardiovasc. Pharmacol. 37, 619-629. doi: 10.1097/00005344-200105000-00013
49. Pang, R. Q., Pan, X. H., Long, P. R., Qin, M., and Ya-Lin, W. U. (2004). Effect of breviscapine on the proliferation of rabbit vascular smooth muscle cells. Chin. J. Arterial Lerosis 12, 395-398
50. Patel, T., Zhou, J., Piepmeier, J. M., and Saltzman, W. M. (2012). Polymeric nanoparticles for drug delivery to the central nervous system. Adv. Drug Deliv. Rev. 64, 701-705. doi: 10.1016/j.addr.2011.12.006
51. Peng, D., and Ye, G. U. (2011). Clinical observation on breviscapine injection on unstable angina pectoris combined with hyperlipidemia. J. Hubei Univ. Chin. Med. 13, 15-17
52. Poulter, N. R., Prabhakaran, D., and Caulfield, M. (2015). Hypertension. Lancet 386, 801-812. doi: 10.1016/S0140-6736(14)61468-9
53. Qin, M., Liu, R., Liu, G., and Dong, F. (2012). Effects of breviscapines injections on cyp activities in rat liver microsomes in vitro. China Pharm. 15, 147-150
54. Rapoport, R. M., Draznin, M. B., and Murad, F. (1983). Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 306, 174-176. doi: 10.1038/306174a0
55. Robinson, J., Hartling, L., Vandermeer, B., Crumley, E., and Klassen, T. P. (2005). Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Database Syst. Rev. 5:CD004370. doi: 10.1002/14651858.CD004370.pub2
56. Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809. doi: 10.1038/362801a0
57. Ross, R. (1999). Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126. doi: 10.1056/NEJM199901143400207
58. Ruparelia, N., Chai, J. T., Fisher, E. A., and Choudhury, R. P. (2017). Inflammatory processes in cardiovascular disease: a route to targeted therapies. Nature Reviews Cardiology 14, 133-144. doi: 10.1038/nrcardio.2017.33
59. Salles, J. I., Duarte, M. E., Guimarães, J. M., Lopes, L. R., Vilarinho, C. J., Aguiar, D. P., et al. (2016). Vascular endothelial growth factor receptor-2 polymorphisms have protective effect against the development of tendinopathy in volleyball athletes. PLoS ONE 11:e0167717. doi: 10.1371/journal.pone.0167717
60. Shen, C. Q., Liu, Z. F., Ya-Ying, W. U., Yao, X. I., and Qian, Y. M. (2014). Clinical study of breviscapine injection on the treatment of unstable angina pectoris patients with coronary heart disease. Yunnan J. Tradit. Chin. Med. Mater. Med. 35, 23-26
61. Shen, Z., Lei, W., Li, D., and Chen, Z. (2000). Inhibitory effects of Erigeron breviscapus flavones on platelet aggregation and thrombosis. Nat. Prod. Res. Dev. 12, 22-25
62. Shi, L., Xie, Y., Liao, X., Chai, Y., and Luo, Y. (2015). Shenmai injection as an adjuvant treatment for chronic cor pulmonale heart failure: a systematic review and meta-analysis of randomized controlled trials. BMC Complement. Altern. Med. 15:418. doi: 10.1186/s12906-015-0953-4
63. Shi, Z. R., and Ding, J. B. (2009). Observe the curative effect of breviscapine in the treatment of 39 cases of hypertensive cerebral hemorrhage. Chin. J. Diffic. Complicat. Cases 8, 219-220
64. Song, Y., Zhang, H. M., Ma, J. J., and Li, C. L. (2011). Effects of scutellarein on thrombosis and hemorheology in rats. Chin. J. New Drugs 20, 1446-1449
65. Tang, C. J., Zi-Cheng, L. I., Deng, C. Y., Kuang, S. J., and Qian, W. M. (2009). Effect of breviscapin on I_(na) channel current in isolated rat ventricular myocytes. Chin. J. Pathophysiol. 25, 647-650
66. Tare, M., Parkington, H. C., Coleman, H. A., Neild, T. O., and Dusting, G. J. (1990). Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 346, 69-71. doi: 10.1038/346069a0
67. Tian, L. H., Zhao, L. Z., Gu, J., Cai, J., and Yu, L. (2014). Breviscapine listed on progress of new varieties and dosage form research. China J. Chin. Mater. Med. 39, 3719-3722
68. Tian, X. Z. (2010). Clinical observation of breviscapine in the treatment of chronic heart failure. Med. Innov. China 7, 54-55
69. Voelkel, N. F., Gomezarroyo, J., Abbate, A., and Bogaard, H. J. (2013). Mechanisms of right heart failure-a work in progress and a plea for failure prevention. Pulm. Circ. 3, 137-143. doi: 10.4103/2045-8932.109957
70. Walsh, L. J. (2003). Mast cells and oral inflammation. Crit. Rev. Oral Biol. Med. 14, 188-198. doi: 10.1177/154411130301400304
71. Wang, C., Li, Y., Gao, S., Cheng, D., Zhao, S., and Liu, E. (2015). Breviscapine injection improves the therapeutic effect of western medicine on angina pectoris patients. PLoS ONE 10:e0129969. doi: 10.1371/journal.pone.0129969
72. Wang, H. B. (2000). Effect of Erigeron injection in renal early function of patients of primary hypertension in elderly. Mod. J. Integr. Tradit. Chin. West. Med. 18, 1744-1745
73. Wang, J., Ji, S. Y., Liu, S. Z., Jing, R., and Lou, W. J. (2015). Cardioprotective effect of breviscapine: inhibition of apoptosis in h9c2 cardiomyocytes via the pi3k/akt/enos pathway following simulated ischemia/reperfusion injury. Pharmazie 70, 593-597
74. Wang, J., Xiong, X., and Feng, B. (2013). Cardiovascular effects of salvianolic acid B. eCAM 2013:247948. doi: 10.1155/2013/247948
75. Wang, J., Yao, K., Yang, X., Liu, W., Feng, B., Ma, J., et al. (2012). Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. eCAM 2012:714805. doi: 10.1155/2012/714805
76. Wang, K. L., Huang, Y. H., and Zhang, Y. F. (2009). Observe the effects of breviscapine in exercise tolerance in patients with acute myocardial infarction after received a successful intravenous thrombolytic treatment. Proc. Clin. Med. 8, 1907-1909
77. 2+-cycling proteins in streptozotocin-induced diabetic rats. Acta Diabetol. 47, 209-218. doi: 10.1007/s00592-009-0164-x
78. Wang, S. M., and Wang, D. B. (2009). Breviscapine in the treatment of 30 children with viral myocarditis. Herald Med. 28, 599-600
79. Wang, Y., Ji, M., Chen, L., Wu, X., and Wang, L. (2013). Breviscapine reduces acute lung injury induced by left heart ischemic reperfusion in rats by inhibiting the expression of icam-1 and il-18. Exp. Ther. Med. 6, 1322-1326. doi: 10.3892/etm.2013.1287
80. Wang, Y., Yang, X., Liu, H., and Tang, X. (2003). Study on effects of Erigeron breviscapus extract on anticoagulation. J. Chin. Med. Mater. 26, 656-658
81. Wei, J. P., Li, J., Shi, Z., and Wang, Y. J. (2010). Inhibitory effect of Erigeron injection on the progression of atherosclerosis in rabbits. Lishizhen Med. Mater. Med. Res. 21, 750-751
82. Wen, J. L., and Ruan, S. (2004). Clinical observation of 36 cases of Erigeron Injection in the treatment of elderly patients with hyperlipidemia. Guangdong Med. J. 25, 163
83. Wu, T. (2011). The Total Synthesis of a Flavonoid Glyeoside Apigenin-7-O-p-D-Glucuronid. Master's thesis, Kunming University of Science and Technology, Kunming
84. Xiuqin, L. I. (2006). Activation of breviscapine to calcium-activated potassium channels in rat aortic smooth muscle. J. Clin. Cardiol. 22, 351-353
85. Xu-Feng, L. I., Liu, F., Jiang, T. L., Wang, Z. J., Han, Y. H., and Zhi-Hong, W. U. (2010). Efficacy of compound danshen drop pill in 42 patients with early acute myocardial infarction. Chin. J. New Drugs 18, 1699-1702
86. Yan, L., Huang, H., Tang, Q. Z., Zhu, L. H., Wang, L., Liu, C., et al. (2010). Breviscapine protects against cardiac hypertrophy through blocking PKC-alpha-dependent signaling. J. Cell. Biochem. 109, 1158-1171. doi: 10.1002/jcb.22495
87. Yang, N. R., and Chen, Q. X. (2013). The effect observation of breviscapine for improving PCI curative myocardial function. Chin. J. Mod. Drug Appl. 7, 23-24
88. Yang, W., Cheng, H., Xie, Y. M., Yang, H., and Zhuang, Y. (2012). Dengzhanxixin injection using character analysis in clinical based on real world his database. China J. Chin. Mater. Med. 37, 2718-2722
89. Yang, X., Xiong, X., Wang, H., and Wang, J. (2014). Protective effects of panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies. Evid. Based Complement. Alternat. Med. 2014:204840. doi: 10.1155/2014/204840
90. Yu, H., Zhang, H., Zhao, W., Guo, L., Li, X., Li, Y., et al. (2016). Gypenoside protects against myocardial ischemia-reperfusion injury by inhibiting cardiomyocytes apoptosis via inhibition of chop pathway and activation of pi3k/akt pathway in vivo and in vitro. Cell. Physiol. Biochem. 39, 123-136. doi: 10.1159/000445611
91. Yu, X. P. (2011). Study on effect of breviscapine injection in the treatment of patients with hyperlipidemia and its mechanism. Pract. Clin. J. Integr. Tradit. Chin. West. Med. 11, 20-21
92. Yunnan Institute of Materia Medica (1976). Study on the chemical constituents of Erigeron breviscapus. Chin. Tradit. Herbal Drugs 11, 11-14. Yunnan institute of materia medica as
93. Zhang, F. (2014). The effect of breviscapine on heart failure patients with normal ejection fraction. Guangdong Med. J. 35, 3254-3256
94. Zhang, H., Wang, X. Y., Liu, Y., Chai, L. J., Wang, H., Zhang, B. L., et al. (2009). Effects of dengzhan xixin injection on inflammatory cytokine production in rat cardiac microvascular cells induced by tumor necrosis factor. J. Chin. Pharm. Sci. 44, 1791-1795
95. Zhang, Q. M., and Zhang, F. L. (2012). Clinical observation on the curative effect of breviscapine powder injection in treating heart stroke of coronary heart disease. Tianjin J. Tradit. Chin. Med. 29, 133-135
96. Zhang, R. W., Zhang, Y. L., Wang, J. S., Lin, Y. Y., and Shang, B. (1988). Isolation and identification of flavonoids from shortscape fleabane (Erigeron breviscapus). Chin. Tradit. Herb Drugs 19:7
97. Zhang, S., Liu, J. Y., Zhao, L., Lei, K., and Liu, Y. (2016). Analysis of 204 cases of adverse drug reactions caused by breviscapine injection. Chin. J. Hosp. Pharm. 36, 1585-1588
98. Zhang, Y. H. (2014). Effect of Wenxin Granule combined with metoprolol on major cardiovascular acute myocardial infarction after PCI. Chin. J. Integr. Med. Cardiol. 12, 180-182
99. Zhao, G. (2010). Experimental study of effect of combining breviscapine with ischemic/preconditioning on the expression of myocardial protein tumor necrosis factor-a, nuclear factor-kappa b during myocardial ischemia/reperfusion in rabbits. J. Clin. Cardiol. 8, 631-634
100. Zhao, Z. G., Gao, H. C., and Wang, A. G. (2008). Clinical Safety and Rational Application of Injection. Beijing: Chemical Industry Press
101. Zheng, C., Ou, W., Shen, H., Zhou, Z., and Wang, J. (2015). Combined therapy of diabetic peripheral neuropathy with breviscapine and mecobalamin: a systematic review and a meta-analysis of Chinese studies. Biomed. Res. Int. 2015:680756. doi: 10.1155/2015/680756
102. Zheng, G., Dong, Y., and Liang, Y. (1998). Effects of breviscapine on isolated rat thoracic aortic ring. Chin. Tradit. Herbal Drugs 10, 680-683
103. Zhong, H., Deng, Y., Wang, X., and Yang, B. (2005). Multivesicular liposome formulation for the sustained delivery of breviscapine. Int. J. Pharm. 301, 15-24. doi: 10.1016/j.ijpharm.2005.04.001
104. Zhou, H., Chen, X., Chen, L., Zhou, X., Zheng, G., Zhang, H., et al. (2014). Anti-fibrosis effect of scutellarin via inhibition of endothelial-mesenchymal transition on isoprenaline-induced myocardial fibrosis in rats. Molecules 19, 15611-15623. doi: 10.3390/molecules191015611
105. Zhou, Q. S., Zhao, Y. M., Bai, X., Li, P. X., and Ruan, C. G. (1992). Effect of new-breviscapine on fibrinolysis and anticoagulation of human vascular endothelial cells. Acta Pharmacol. Sin. 13, 239-242